The main activity of the Group is manufacturing APIs & Custom Manufacturing for the pharmaceutical industry.
A qualiﬁed team of professionals forms the nucleus of the Research and Development and innovations Department (R & D & i). They are responsible for studying and designing the synthesis process and the corresponding analytical methods of the diverse organic compounds.
Our facilities and our background in the synthesis of complex organic compounds allow us to offer our customers a wide range of synthetic processes applicable industrial-wise
The R&D team is complimented by a Pilot Plant Unit, in which synthesis pathways are tested in small scale before being transferred to industrial level. Structured into two shifts, the Pilot Plant is working according to cGMP.
We constantly are putting great effort into developing synthesis downstreams for new APIs under commercial, industrial and intellectual property feasibility criteria.
In a highly competitive and growing market, MOEHS has been able to stand as one of the main participants worldwide.
The success in this market segment depends on the confidence that the customer has for the industrial and technical response that your company may provide. The more than 50 years of experience behind us is forging our way to marketing our technical skills.